ResMedRMD

NYSE · USA · Segment 7 of 8 in the Medicine, pharma & life science value chain: Medtech & devices

CPAP machines and masks for sleep apnea, sold with cloud software, next to a wider respiratory equipment range.

Medtech & devices: Medical equipment and devices, from surgery and cardiology to robotics.

Key metrics

Market cap

$32.7B

Price

$232.45

Today

+0.4%

Return YTD

−3.9%

Return 1Y

−19.7%

P/E

21.5

P/S

5.8

P/B

5.0

Data as of 2026-08-25 · updates daily after U.S. close

Theme exposure

Sleep & respiratorySleep apneaRespiratory equipmentDigital health

In the value chain

Products & services

CPAP devices & masks
Sleep & respiratory equipment
Digital health software

Competitors

Philips
Fisher & Paykel Healthcare
Compumedics

Risks

GLP-1 impact on sleep apnea
Competition

Supply chain

Supplies →

Cardinal HealthCAH

Full supply chain for RMD →

Same segment: Medtech & devices

Intuitive SurgicalISRG StrykerSYK MedtronicMDT Boston ScientificBSX Edwards LifesciencesEW Becton DickinsonBDX GE HealthCareGEHC Zimmer BiometZBH

Compare RMD

RMD vs ISRG RMD vs SYK RMD vs MDT RMD vs BSX RMD vs EW RMD vs BDX

See where ResMed sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →